R&D
Fugenbio continues to advance research on bioactive extracts and their applications in real-life health solutions,
backed by decades of expertise in microbial cultivation.
From the discovery of a novel microorganism, Ceriporia lacerata, to efficacy testing, functional expansion, and commercialization,
our R&D journey reflects a deep commitment to science and innovation.
Discovering Ceriporia
Identified Ceriporia lacerata,
a rare strain with potential benefits for diabetes and cancer.
Validating Its Potential
Developed extraction tech and verified blood sugar support
through preclinical and clinical studies.
Broadening the Evidence
Found additional effects on blood pressure, liver health, and skin safety.
Secured patents and presented at major conferences.
From Lab to Life
Commercialized as a cosmetic ingredient and under registration
as a functional health supplement in Korea.